Bora follows the Access to Medicine Index guidelines to shape our policies and execution strategies. We are committed to making products available at affordable prices and ensuring that patients can access the treatments they need.
Promise of Support™ Program
Upsher-Smith, Bora’s specialty pharma brand, launched the Promise of Support™ Program to provide services for rare disease patients. The program included value-added support for patients and families navigating through complex treatments and their rare disease patient journey.
Rare diseases often impose significant emotional, physical and financial burdens. Upsher-Smith continuously studies each disease area to provide better support and reduce financial and medical gaps in the treatment journey.
Currently, the program covers 3 products:
- Vigadrone® powder for oral solution
- Vigadrone® tablets
- TORPENZ™ tablets
Drug Donation Project
Guided by the mission “Contributing to Better Health All Over the World,” Bora Pharmaceuticals embraces its social responsibility by supporting healthcare access in underserved communities.
By proactively offering medicines to populations with economic or geographic barriers, Bora aims to promote health equity. Upsher-Smith donated over USD $162,858 and USD$ 165,332 in 2023and 2024, respectively.
Responsible Pricing
Bora applies a tiered pricing strategy aligned with World Health Organization Guidelines for National Drug Pricing Policies. We analyze market conditions — such as GDP, income levels, distribution structures, and insurance reimbursement mechanisms—to set fair and locally appropriate prices. This ensures that drug prices are reasonable and accessible to those who need them.